- Activity pressure is positive on the latest completed week.
SKIN
NASDAQ
Week ended 31 Jul 2026
Weekly Investor Report
Beauty Health Co · Consumer Defensive · Household & Personal Products
Latest close
0.69 USD
-6.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -27.2% below the Trend Line and sits at 6.3% of its 52-week range. The latest completed week returned -6.4%, after a -5.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is mixed with 25/100 conviction, while the latest news-sentiment score is 42/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.
Setup score
27
out of 100
Latest Close
0.69 USD
31 Jul 2026
1W Return
-6.4%
latest completed week
4W Return
-5.6%
short-term follow-through
12W Return
18.2%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 43.15% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.4%
Latest completed week; four-week move -5.6%.
Indicator stack
11/86
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.15%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Mixed
25/100 conviction; expected move 44.4%.
News sentiment
42/100
39 relevant articles in the latest sentiment read.
Event risk
3d
Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -27.2% below the Trend Line and sits at 6.3% of its 52-week range. The latest completed week returned -6.4%, after a -5.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0512-week average 0.03
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.6% over four weeks, 18.2% over 12 weeks, and -55.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.76Latest activity-pressure read.
Pressure change280.2%Four-week change in activity pressure.
Leadership-51.40Latest relative-leadership reading.
RS change4.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 84%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength82/100Blend of value, momentum, and quality. Underlying universe rank 19; rank 1 is best.
Value90/100Relative valuation strength. Underlying universe rank 11; rank 1 is best.
Quality79/100Profitability and accounting quality. Underlying universe rank 22; rank 1 is best.
Momentum4/100Medium-term price momentum. Underlying universe rank 97; rank 1 is best.
Growth18/100Revenue and earnings growth. Underlying universe rank 83; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework71/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.3x Market value relative to trailing revenue.
- EV / EBITDA
- 5.8x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 12.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 64.9% Gross profit retained from each unit of revenue.
- Operating margin
- 6.6% Operating profit retained from revenue.
- Free-cash-flow margin
- 11.1% Free cash flow generated from revenue.
- Return on invested capital
- 6.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -8.2% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -22.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 3.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningMixed
SKIN shows mixed options pressure with a 25/100 conviction score, put-call volume ratio of n/a, expected move of 44.4%, and Sharemaestro trend signal inactive.
Conviction25/100
Expected move44.4%
Put/call volume
Insider activity-
No recent insider transactions are stored for this company.
News sentiment42/100
Weighted news tone is neutral across 39 relevant articles.
3 positive · 22 neutral · 14 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings3dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move44.4%Nearest-chain priced movement where available.
52-week drawdown-74.5%Distance below the 52-week high.
13-week volatility15.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher13 of 2613 weeks finished lower.
Best week+25.3%Week of 10 Jul.
Worst week-32.8%Week of 8 May.
Latest week-6.4%Week of 31 Jul.
Shape of recent returns
Strong gains10
Modest gains3
Flat weeks0
Modest losses2
Sharp losses11
Recent vol15.0%13-week weekly-return volatility.
Base vol12.1%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew9.2% / -9.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Consumer Defensive
4-week rank- / 100
Group average0.9%
Trend breadth48.0%
Trend48.0%active weekly trend signals
MD57.0%positive activity pressure
RS36.0%positive relative leadership
Four-week leaders
IndustryUS Household & Personal Products
4-week rank23 / 28
Group average-0.4%
Trend breadth42.9%
Trend42.9%active weekly trend signals
MD82.1%positive activity pressure
RS28.6%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape24/100
Trend, activity pressure, participation, and risk combine to a 24/100 tape read.
Indicator analysis16/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.05; No reversal markers Next-Week ExpectancyNegative 43.15%Next-week expectancy is negative with a 43.15% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors65/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 76; Buyback Yield rank 55; Small Cap Core rank 16 SVQF71/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 214.5 of 726 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Options42/100SKIN shows mixed options pressure with a 25/100 conviction score, put-call volume ratio of n/a, expected move of 44.4%, and Sharemaestro trend signal inactive.
Mixed · Options-market disagreement · Expected move 44.4% Sentiment42/100Weighted news tone is neutral across 39 relevant articles.
SkinHealth Systems (Nasdaq: SKIN) seeks approval for reverse split to protect listing Insiders50/100No recent insider transaction evidence is stored.
Earnings3dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 0.69 USD | -6.4% | 0.94 USD | 2.12 USD | 0.76 | -51.40 | 5.1M | Off |
| 24 Jul 2026 | 0.73 USD | -13.2% | 0.96 USD | 2.16 USD | 0.74 | -48.66 | 3.6M | Off |
| 17 Jul 2026 | 0.84 USD | -7.2% | 0.99 USD | 2.21 USD | 0.67 | -42.89 | 4.0M | Off |
| 10 Jul 2026 | 0.91 USD | 25.3% | 1.01 USD | 2.25 USD | 0.21 | -41.86 | 100.2M | Off |
| 3 Jul 2026 | 0.73 USD | 10.0% | 1.03 USD | 2.30 USD | -0.42 | -53.68 | 2.5M | Off |
| 26 Jun 2026 | 0.66 USD | -0.4% | 1.05 USD | 2.35 USD | -0.78 | -58.63 | 17.8M | Off |
| 19 Jun 2026 | 0.66 USD | 1.4% | 1.08 USD | 2.40 USD | -0.83 | -61.20 | 2.3M | Off |
| 12 Jun 2026 | 0.65 USD | 7.6% | 1.10 USD | 2.45 USD | -0.77 | -61.40 | 2.6M | Off |
| 5 Jun 2026 | 0.61 USD | -21.5% | 1.12 USD | 2.50 USD | -0.71 | -63.89 | 3.9M | Off |
| 29 May 2026 | 0.77 USD | 12.5% | 1.15 USD | 2.55 USD | -0.71 | -56.84 | 8.3M | Off |
| 22 May 2026 | 0.69 USD | 6.8% | 1.17 USD | 2.60 USD | -0.93 | -61.18 | 5.6M | Off |
| 15 May 2026 | 0.64 USD | 11.0% | 1.19 USD | 2.65 USD | -1.00 | -63.85 | 7.7M | Off |
| 8 May 2026 | 0.58 USD | -32.8% | 1.22 USD | 2.71 USD | -1.00 | -68.13 | 10.5M | Off |
| 1 May 2026 | 0.86 USD | 1.5% | 1.25 USD | 2.77 USD | -1.02 | -51.06 | 3.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.